[1] Harald R, Udo H. mechanisms of peripheral tolerance. Nutr Res. 1998;18(8):1327-1333.[2] Newell Kenneth A. Clinical transplantation tolerance. Sem Immunopathol. 2011;33(2): 91-104.[3] Semple JW. Infections, antigen-presenting cells, T cells, and immune tolerance: their role in the pathogenesis of immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23(6): 1177-1192. [4] Roy C. Immunological tolerance: the liver effect. J Gastroenterol Hepatol. 2003;17 :S488-490.[5] 彭勇.细胞毒性T淋巴细胞相关抗原4-Ig与移植器官免疫耐受的研究进展[J].中国现代普通外科进展, 2002, 5(3):133-135.[6] 王琳,窦科峰. T淋巴细胞与肝移植免疫[J].国外医学: 外科学分册,2005,32(5):339-342.[7] Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol. 2003;3:51-62.[8] Semple JW. Immunobiology of T helper cells and antigen-presenting cells in autoimmune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998 ;424:41-45.[9] Masaomi O, Takuma F, Mareki O, et al. Peripheral tolerance of antigen-specific Th cells induced with polyethylene glycol-conjugate of protein antigen. Open J Immunol. 2013; 3 (2):62-70.[10] Bolesiawski E, Conti F, Sanquer S, et al. Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. Transplatation. 2004; 77:1815-1820.[11] 高银杰,李捍卫,董宁. CD4+辅助性T细胞及其细胞因子与肝移植后的免疫[J].中国组织工程研究与临床康复,2009,13(53): 10521-10524.[12] Shirwan H,Barwari L,Khan NS. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.Transplantation. 1998; 66(12):1802-1809.[13] Pirenne J, Kitade H, Kawai M, et al. Regulatory cells, Th1/Th2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation. 2005;79: S25-27.[14] Chen Y , Chen J , Liu Z, et al. Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats. Transplant Proc. 2008;40(8):2691-2695.[15] 尤鹏,刘玉兰,陈国栋.大鼠肝移植自发免疫耐受模型T淋巴细胞亚群的变化[J].中华肝脏病杂志, 2005,13(9):698-699.[16] Harrison OJ, Powrie FM. Regulatory T cells and immune tolerance in the intestine. Cold Spring Harb Perspect Biol. 2013;5(7). pii: a018341. doi: 10.1101/cshperspect.a018341.[17] Tapirdamaz O,Praviea V,Metselaar HJ. Polymorphisms in the T cell regulatory gene cytotoxie T lymphocyte antigen 4 influence therate of acute rejection after liver transplantation. Gut. 2006;55(6):863-868.[18] Demirkiran A,Kok A,Kwekkeboom J. Low circuiting regnla-tory T-cell levels after acute rejeefion in liver transplantation. Liver Transpl. 2006;12(2):277-284.[19] Tokita D, Mazariegos GV, Zahorchak AF, et al. High PDL1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation. 2008;85:369-377.[20] 郭业磊,陈钰.CD8+ T调节细胞的研究进展[J].细胞与分子免疫学杂志,2009,25(8):762-763.[21] 徐佳,侯桂华.移植免疫耐受中调节性T细胞的研究进展[J].国际免疫学杂志,2007,30(6):393-398.[22] Yoshizawa A, Ito Y, Li T, et al. The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation. Transplant Proc. 2005; 37(1):37-39.[23] 张梦瑶,孙晓莉,唐丽,等. Cbl-b调控 T 细胞的免疫耐受[J].细胞与分子免疫学杂志,2012,28(4):445-447.[24] 才华,郭楠,侯治富. CD4+ CD25+调节性T细胞的研究进展[J]. 吉林大学学报,2007,33(6):1110-1112. [25] Chen YL, Gou KY, Li YH, et al.Comparison of effects of Tju103 and CTLA4-Ig on induction of tolerance of T lymphocytes. Chi J Modern Med. 2004;(16):1-5.[26] Shi LB, Zhang HW, Cui YY. Implication of different expression of IL-2 mRNA and IL-10 mRNA in CD4(+)CD25(+)T cell induced immune tolerance of liver transplantation in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008;20(5):257-260.[27] Bittmann I, Bottino A, Baretton GB, et al. The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation--a clinico-pathological study. Virchows Archiv. 2003;443(4): 541-548.[28] Sakurai Y, Matsutanit T, Yoshioka T, et al. Alterations of T cell receptor Vbeta repertoire of CD8 T lymphocytes in immune tolerance induction in two hemophilia A patients with inhibitors. Vojnosanit Pregl. 2011;68(12):1047-1050.[29] Schulz-Juergensen S, Marischen L, Wesch D, et al. Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression. Pediatr Transplant. 2013;17(4):348-354.[30] 余希,施明,刘振文,等. 肝移植免疫排斥与免疫耐受机制研究进展[J]. 细胞与分子免疫学杂志,2012,28(7):761-763.[31] Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med. 1998;338(25):1813-1821.[32] Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol. 2001; 1(3):233-239.[33] Starzl TE. Immunosuppressive therapy and tolerance of organ allografts. Nengl J Med. 2008;358:407-411.[34] Kirk AD. Meteorology and tolerance. Am J Transplant. 2006;6: 645-646.[35] Martinez OM, Rosen HR. Basic concepts in transplantimmunology. Liver Transpl. 2005;11(4): 370-381.[36] Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci USA. 2004;101(suppl 2):14607-14614. [37] Orlando G, Soker S, Wood K. Operational tolerance after liver traqnsplantation. J Hepatol. 2009;50(6): 1247-1257.[38] Feng J F , Chen F , Liu H, et al. Induction of immune tolerance by pre-infusion of apoptotic lymphocytes derived from peripheral blood of donor rats before liver transplantation. Minerva Chir. 2013 68(2):183-189.[39] Verbinnen B, Vsn Gool SW, Ceuppens JL. Blocking costimulatory pathways: prospects for inducing transplantation tolerance. Immunotheraty. 2010;2:497-509.[40] Ravindranath MH, Pham T, Ozawa M, et al. Antibodies to HLA-E may account for the mon-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients. Int Immunol. 2012;24:43-57.[41] Oleary JG, Kaneku H, Susskind BM, et al. High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Ttansplant. 2011;11:1868-1876.[42] Ohe H, Waki K, Yoshitomi M, et al. Factors affecting operational tolerance after pediatric living-donor liver transplantation:impact of early post-transplant events and HLA match. Translp Int. 2012;25:97-106.[43] Stewart ZA,Locke JE,Montgomery RA, et al. ABO-incompatible deceased donor liver transplantation in the Uniged States: a national registry analysis. Liver Transpl. 2009; 15(8):883-893.[44] Uchiyama H, Mano Y, Taketomi A, et al. Kinetics of anti-blood type isoagglutinin titers and B lymphocytes in ABO-incompatible livingdonor liver transplantation with rituximab and plasma exchange. Transplantation.2011;92: 1134-1139.[45] Wu J, Ye S, Xu X, et al. Recipient Outcomes after ABO-Incompatible liver transplantation: A systematic review and Meta-Analysis. PLos One. 2011;6(1):e16521.[46] Testa G, Vidanovic V, Chejfec G, et al. Adult living-donor liver transplantation with ABO-incompatible grafts. Transplantation. 2008;85(5):681-686.[47] Jahr H , Wolff H. The liver--an immunologically privileged organ? Allerg Immunol (Leipz). 1989;35(3):155-166.[48] Toyokawa H, Nakao A, Bailey RJ, et al. Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl. 2008;14:346-357.[49] Steger U, Denecke C, Sawitzki B, et al. Exhaustive differentiation of alloreactive CD8+T cells: critical for determination of graft acceptance or rejection. Transplantation. 2008;85:1339-1347.[50] Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361:1502-1510.[51] Sanchez-Fueyo A, Weber M, Domenig C, et al. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol. 2002;168(5):2274-2281.[52] Roussey-Kesler G, Giral M, Moreau A, et al. Clinical operational tolerance after kidney transplantation. Am J Translpant. 2006;6(4)645-646.[53] Mazariegos G, Zahorchak AF, Reyes J, et al. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant. 2005;5:314-322.[54] Chen Y, Liu Z, Liang SS, et al. Role of Kupffer cells in the induction of tolerance of orthotopic liver transplantation in rats. Liver Transpl. 2008;14:823-836.[55] Bettens F, Tiercy JM, Campanile N, et al. Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity. Liver Transplantation. 2005;11(3):290-297.[56] Araujo MB, Leonardi LS, Leonardi MI, et al. Prospective analysis between the therapy of immunosuppressive medication and allogeneic microchimerism after liver transplantation. Transpl Immunol. 2009;20:195-198.[57] Alexander SI, Smith N, Hu M, et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med. 2008;358:369-374. |